InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2025-06-02 00:00:00 ET · period of report 2025-06-01 · accession 0001576280-25-000157 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-02 2025-06-01 GH Chudova Darya CTO M - OptEx $0.00 +316 80.0K +0.4% $0
D 2025-06-02 2025-06-01 GH Chudova Darya CTO F - Tax $40.62 -161 79.8K -0.2% -$6,540
D 2025-06-02 2025-06-01 GH Chudova Darya CTO M - OptEx $0.00 -316 316 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-01 M A 316 $0.00 79,973 D — —
2 Common Common Stock 2025-06-01 F D 161 $40.62 79,812 D — — (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
3 Derivative Restricted Stock Units 2025-06-01 M D 316 $0.00 316 D $0.00 · — to — 316 Common Stock (F2) The restricted stock unit award was granted on November 2, 2021, of which 3,157 shares were outstanding on May 3, 2023, when the reporting person was elected as an officer. These shares vest in equal quarterly installments on the anniversary of September 1, 2022 and fully vest on September 1, 2025. (F3) Not applicable for Restricted Stock Units.